FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4299285416> ?p ?o ?g. }

• W4299285416 endingPage "99" @default.
• W4299285416 startingPage "88" @default.
• W4299285416 abstract "Immune checkpoint inhibitors (ICIs) may induce persistent immune-related adverse events (irAEs). We investigated persistent irAEs and implications on patients' lives compared to non-ICI-induced autoimmune diseases (AIs).The multicentre, cross-sectional study comprised 200 patients with cancer ≥12 weeks after ICI cessation (ICI-patients) and 2705 patients with AIs (AI-patients), recruited in German outpatient clinics and support groups. The prevalence of persistent irAEs subdivided in long-term (12 weeks to <12 months) and chronic irAEs (≥12 months) since ICI discontinuation, health-related quality of life (HRQoL) using the EuroQol 5D-5L (EQ-Index/VAS score), and burden of autoimmune symptoms and respective therapies were assessed.Long-term/chronic irAEs occurred in 51.9%/35.5% of outpatient ICI-patients, including arthralgia (16.7%/16.1%), myalgia (13.0%/14.0%), hypothyroidism (11.1%/10.8%), xerostomia (7.4%/8.6%), vitiligo (13.0%/7.5%) and hypophysitis (9.3%/7.5%). ICI-patients with long-term/chronic irAEs reported clinically significantly reduced HRQoL compared to ICI-patients without long-term/chronic irAEs (EQ-Index score: 0.767/0.752 versus 0.920/0.923, p < 0.001/0.001; EQ-VAS score: 52.2/52.0 versus 63.6/74.7, p =/< 0.040/0.001). Multiple linear regression analyses confirmed clinically significant reductions in HRQoL scores by chronic irAEs (EQ-Index/VAS score: -0.163/-23.4, p < 0.001/0.001). HRQoL, burden of autoimmune symptoms and burden of respective therapies in ICI-patients with chronic irAEs were similar to AI-patients with non-exacerbated AIs. Patients with chronic irAEs felt inadequately informed about side-effects compared to patients without chronic irAEs (p < 0.001).Persistent irAEs impose a significant burden on patients after ICI cessation. Especially in early tumour stages, risk-benefit ratios must be carefully evaluated, and patients need to be informed about potential long-term sequelae." @default.
• W4299285416 created "2022-10-02" @default.
• W4299285416 creator A5013657307 @default.
• W4299285416 creator A5021665579 @default.
• W4299285416 creator A5031315234 @default.
• W4299285416 creator A5034596933 @default.
• W4299285416 creator A5054610818 @default.
• W4299285416 creator A5059390129 @default.
• W4299285416 creator A5063724363 @default.
• W4299285416 creator A5084788512 @default.
• W4299285416 creator A5086348286 @default.
• W4299285416 date "2022-11-01" @default.
• W4299285416 modified "2023-10-16" @default.
• W4299285416 title "Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life" @default.
• W4299285416 cites W1990166011 @default.
• W4299285416 cites W1997494515 @default.
• W4299285416 cites W2060638484 @default.
• W4299285416 cites W2063765032 @default.
• W4299285416 cites W2098428600 @default.
• W4299285416 cites W2112121482 @default.
• W4299285416 cites W2123363005 @default.
• W4299285416 cites W2153836018 @default.
• W4299285416 cites W2157665983 @default.
• W4299285416 cites W2164826904 @default.
• W4299285416 cites W2338994579 @default.
• W4299285416 cites W2549481046 @default.
• W4299285416 cites W2786816161 @default.
• W4299285416 cites W2788008365 @default.
• W4299285416 cites W2810896552 @default.
• W4299285416 cites W2901974641 @default.
• W4299285416 cites W2924999601 @default.
• W4299285416 cites W2942494785 @default.
• W4299285416 cites W2946421443 @default.
• W4299285416 cites W2949056079 @default.
• W4299285416 cites W2990928375 @default.
• W4299285416 cites W2997720498 @default.
• W4299285416 cites W3012372578 @default.
• W4299285416 cites W3022139331 @default.
• W4299285416 cites W3037716626 @default.
• W4299285416 cites W3084990964 @default.
• W4299285416 cites W3137634582 @default.
• W4299285416 cites W3148902978 @default.
• W4299285416 cites W3155554393 @default.
• W4299285416 cites W3196207248 @default.
• W4299285416 cites W4210370153 @default.
• W4299285416 cites W4226360696 @default.
• W4299285416 cites W4229079437 @default.
• W4299285416 doi "https://doi.org/10.1016/j.ejca.2022.08.029" @default.
• W4299285416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36198246" @default.
• W4299285416 hasPublicationYear "2022" @default.
• W4299285416 type Work @default.
• W4299285416 citedByCount "13" @default.
• W4299285416 countsByYear W42992854162022 @default.
• W4299285416 countsByYear W42992854162023 @default.
• W4299285416 crossrefType "journal-article" @default.
• W4299285416 hasAuthorship W4299285416A5013657307 @default.
• W4299285416 hasAuthorship W4299285416A5021665579 @default.
• W4299285416 hasAuthorship W4299285416A5031315234 @default.
• W4299285416 hasAuthorship W4299285416A5034596933 @default.
• W4299285416 hasAuthorship W4299285416A5054610818 @default.
• W4299285416 hasAuthorship W4299285416A5059390129 @default.
• W4299285416 hasAuthorship W4299285416A5063724363 @default.
• W4299285416 hasAuthorship W4299285416A5084788512 @default.
• W4299285416 hasAuthorship W4299285416A5086348286 @default.
• W4299285416 hasBestOaLocation W42992854161 @default.
• W4299285416 hasConcept C126322002 @default.
• W4299285416 hasConcept C159110408 @default.
• W4299285416 hasConcept C197934379 @default.
• W4299285416 hasConcept C203014093 @default.
• W4299285416 hasConcept C2778715236 @default.
• W4299285416 hasConcept C2779951463 @default.
• W4299285416 hasConcept C2779980618 @default.
• W4299285416 hasConcept C71924100 @default.
• W4299285416 hasConceptScore W4299285416C126322002 @default.
• W4299285416 hasConceptScore W4299285416C159110408 @default.
• W4299285416 hasConceptScore W4299285416C197934379 @default.
• W4299285416 hasConceptScore W4299285416C203014093 @default.
• W4299285416 hasConceptScore W4299285416C2778715236 @default.
• W4299285416 hasConceptScore W4299285416C2779951463 @default.
• W4299285416 hasConceptScore W4299285416C2779980618 @default.
• W4299285416 hasConceptScore W4299285416C71924100 @default.
• W4299285416 hasLocation W42992854161 @default.
• W4299285416 hasLocation W42992854162 @default.
• W4299285416 hasOpenAccess W4299285416 @default.
• W4299285416 hasPrimaryLocation W42992854161 @default.
• W4299285416 hasRelatedWork W1970734801 @default.
• W4299285416 hasRelatedWork W2083264940 @default.
• W4299285416 hasRelatedWork W2122536851 @default.
• W4299285416 hasRelatedWork W2328367421 @default.
• W4299285416 hasRelatedWork W2361302679 @default.
• W4299285416 hasRelatedWork W2376842615 @default.
• W4299285416 hasRelatedWork W3193583429 @default.
• W4299285416 hasRelatedWork W4249208820 @default.
• W4299285416 hasRelatedWork W4386640344 @default.
• W4299285416 hasRelatedWork W3083702052 @default.
• W4299285416 hasVolume "176" @default.
• W4299285416 isParatext "false" @default.
• W4299285416 isRetracted "false" @default.

• next